ADC Therapeutics SA
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2021 | — | $154.0M | $466.5M |
| Dec 2022 | — | $79.5M | $326.4M |
| Mar 2023 | — | $28.4M | $310.5M |
| Jun 2023 | — | $-19.7M | $347.5M |
| Sep 2023 | — | $-64.2M | $310.4M |
| Dec 2023 | — | $-148.2M | $278.6M |
| Mar 2024 | — | $-194.4M | $234.3M |
| Jun 2024 | — | $-131.7M | $300.1M |
| Sep 2024 | — | $-171.9M | $274.3M |
| Dec 2024 | — | $-202.6M | $250.9M |
| Mar 2025 | — | $-238.2M | $194.7M |
| Jun 2025 | — | $-199.2M | $264.6M |
| Sep 2025 | — | $-238.2M | $234.7M |
| Dec 2025 | — | $-185.8M | $261.3M |
| Mar 2026 | — | $-216.4M | $231.0M |
| Jun 2026 | — | $-228.2M | $219.1M |